Langenhan Joseph M, Griffith Byron R, Thorson Jon S
Laboratory for Biosynthetic Chemistry, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, Wisconsin 53705, USA.
J Nat Prod. 2005 Nov;68(11):1696-711. doi: 10.1021/np0502084.
In an effort to explore the contribution of the sugar constituents of pharmaceutically relevant glycosylated natural products, chemists have developed glycosylation methods that are amenable to the generation of libraries of analogues with a broad array of glycosidic attachments. Recently, two complementary glycorandomization strategies have been described, namely, neoglycorandomization, a chemical approach based on a one-step sugar ligation reaction that does not require any prior sugar protection or activation, and chemoenzymatic glycorandomization, a biocatalytic approach that relies on the substrate promiscuity of enzymes to activate and attach sugars to natural products. Since both methods require reducing sugars, this review first highlights recent advances in monosaccharide generation and then follows with an overview of recent progress in the development of neoglycorandomization and chemoenzymatic glycorandomization.
为了探索药学相关糖基化天然产物中糖成分的作用,化学家们开发了糖基化方法,这些方法适用于生成具有广泛糖苷连接方式的类似物文库。最近,已经描述了两种互补的糖随机化策略,即新糖随机化,一种基于一步糖连接反应的化学方法,该反应不需要任何预先的糖保护或活化;以及化学酶促糖随机化,一种生物催化方法,它依赖于酶的底物混杂性来活化糖并将其连接到天然产物上。由于这两种方法都需要还原糖,因此本综述首先重点介绍单糖生成方面的最新进展,然后概述新糖随机化和化学酶促糖随机化发展的最新进展。